Results 181 to 190 of about 1,675 (195)

Treatment of PTLD: a slow and difficult path

Blood
openaire   +2 more sources

PTLD: Clinical Characteristics and Outcomes in Argentina

Clinical Lymphoma Myeloma and Leukemia, 2017
Fernando Warley, Federico Jauk, Victoria Otero, Maria Florencia Tisi Baña, Marina Bonanno, Dana Kohan, Hernan Garcia Rivello   +6 more
openaire   +1 more source

PTLD – rationale Prävention und Therapie

Nieren- und Hochdruckkrankheiten, 2018
M. Choi, R. Trappe
openaire   +1 more source

Precision Medicine: The Role of the MSIDS Model in Defining, Diagnosing, and Treating Chronic Lyme Disease/Post Treatment Lyme Disease Syndrome and Other Chronic Illness: Part 2

Healthcare, 2018
Phyllis R Freeman, Richard Horowitz
exaly  

Epstein–Barr Virus-Negative Post-Transplant Lymphoproliferative Disorders

American Journal of Surgical Pathology, 2000
Steven H Swerdlow, M A Nalesnik
exaly  

Molecular histogenesis of posttransplantation lymphoproliferative disorders Free

Blood, 2003
Daniela Capello, Alessandro Rambaldi, Gianluca Gaidano   +2 more
exaly  

Improving outcomes in PTLD.

Oncology (Williston Park, N.Y.), 2010
openaire   +1 more source

CMV and EBV-PTLD after liver transplantation

Transplantation Proceedings, 2001
openaire   +2 more sources

Posttransplant Lymphoproliferative Disorders (PTLDs)

2017
exaly  

Genetic variation in the ABCB1 gene associated with post treatment lyme disease syndrome status

Meta Gene, 2019
exaly